Your browser doesn't support javascript.
loading
Just 2% of SARS-CoV-2-positive individuals carry 90% of the virus circulating in communities.
Yang, Qing; Saldi, Tassa K; Gonzales, Patrick K; Lasda, Erika; Decker, Carolyn J; Tat, Kimngan L; Fink, Morgan R; Hager, Cole R; Davis, Jack C; Ozeroff, Christopher D; Muhlrad, Denise; Clark, Stephen K; Fattor, Will T; Meyerson, Nicholas R; Paige, Camille L; Gilchrist, Alison R; Barbachano-Guerrero, Arturo; Worden-Sapper, Emma R; Wu, Sharon S; Brisson, Gloria R; McQueen, Matthew B; Dowell, Robin D; Leinwand, Leslie; Parker, Roy; Sawyer, Sara L.
Afiliación
  • Yang Q; BioFrontiers Institute, University of Colorado Boulder, Boulder, CO 80303.
  • Saldi TK; Department of Molecular, Cellular, and Developmental Biology, University of Colorado Boulder, Boulder, CO 80303.
  • Gonzales PK; BioFrontiers Institute, University of Colorado Boulder, Boulder, CO 80303.
  • Lasda E; BioFrontiers Institute, University of Colorado Boulder, Boulder, CO 80303.
  • Decker CJ; BioFrontiers Institute, University of Colorado Boulder, Boulder, CO 80303.
  • Tat KL; Department of Biochemistry, University of Colorado Boulder, Boulder, CO 80303.
  • Fink MR; HHMI, University of Colorado Boulder, Boulder, CO 80303.
  • Hager CR; BioFrontiers Institute, University of Colorado Boulder, Boulder, CO 80303.
  • Davis JC; BioFrontiers Institute, University of Colorado Boulder, Boulder, CO 80303.
  • Ozeroff CD; BioFrontiers Institute, University of Colorado Boulder, Boulder, CO 80303.
  • Muhlrad D; BioFrontiers Institute, University of Colorado Boulder, Boulder, CO 80303.
  • Clark SK; BioFrontiers Institute, University of Colorado Boulder, Boulder, CO 80303.
  • Fattor WT; Department of Biochemistry, University of Colorado Boulder, Boulder, CO 80303.
  • Meyerson NR; HHMI, University of Colorado Boulder, Boulder, CO 80303.
  • Paige CL; BioFrontiers Institute, University of Colorado Boulder, Boulder, CO 80303.
  • Gilchrist AR; Darwin Biosciences Inc., Boulder, CO 80303.
  • Barbachano-Guerrero A; BioFrontiers Institute, University of Colorado Boulder, Boulder, CO 80303.
  • Worden-Sapper ER; BioFrontiers Institute, University of Colorado Boulder, Boulder, CO 80303.
  • Wu SS; Darwin Biosciences Inc., Boulder, CO 80303.
  • Brisson GR; BioFrontiers Institute, University of Colorado Boulder, Boulder, CO 80303.
  • McQueen MB; Darwin Biosciences Inc., Boulder, CO 80303.
  • Dowell RD; BioFrontiers Institute, University of Colorado Boulder, Boulder, CO 80303.
  • Leinwand L; Department of Molecular, Cellular, and Developmental Biology, University of Colorado Boulder, Boulder, CO 80303.
  • Parker R; BioFrontiers Institute, University of Colorado Boulder, Boulder, CO 80303.
  • Sawyer SL; BioFrontiers Institute, University of Colorado Boulder, Boulder, CO 80303.
Proc Natl Acad Sci U S A ; 118(21)2021 05 25.
Article en En | MEDLINE | ID: mdl-33972412
ABSTRACT
We analyze data from the fall 2020 pandemic response efforts at the University of Colorado Boulder, where more than 72,500 saliva samples were tested for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using qRT-PCR. All samples were collected from individuals who reported no symptoms associated with COVID-19 on the day of collection. From these, 1,405 positive cases were identified. The distribution of viral loads within these asymptomatic individuals was indistinguishable from what has been previously observed in symptomatic individuals. Regardless of symptomatic status, ∼50% of individuals who test positive for SARS-CoV-2 seem to be in noninfectious phases of the disease, based on having low viral loads in a range from which live virus has rarely been isolated. We find that, at any given time, just 2% of individuals carry 90% of the virions circulating within communities, serving as viral "supercarriers" and possibly also superspreaders.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Portador Sano / SARS-CoV-2 / COVID-19 Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Portador Sano / SARS-CoV-2 / COVID-19 Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Año: 2021 Tipo del documento: Article